NanoCube
Health
| Early Detect
| Early Intervene
| Thrive
There is an opportunity to revolutionise medicine with a new early detection, diagnosis and treatment approach. Pancreatic cancer is often not detected until it has advanced because it usually doesn't show symptoms in its early stages. There is also no early screening tool for pancreatic cancer, contributing to poor outcomes for many patients.Leveraging artificial intelligence, we are developing a bioinspired nanorobotics device to:
Early detect pancreatic cancer forming at its earliest stage
Monitor treatment progress in real-time
Deliver targeted treatment
Watch the Dare to Hope documentary
An insight into the life of former AFL Hawthorn player Paul Dear and his family, following his diagnosis of terminal Stage 4 pancreatic cancer.
Available to stream exclusively on SBS on Demand and Kayo Sports
The technology under development is not yet commercially available. While we continue to advance product development, we strongly encourage people to know the signs of pancreatic cancer to promote earlier diagnosis.
Check out our careers page or follow us on LinkedIn to stay up-to-date with current employment opportunities at NanoCube Health.
Read about the latest news and issues relevant to nanotechnology, artificial intelligence and medical innovation.